BioSante Pharmaceuticals, Inc. (BPAX) to Present at the Lazard Capital Markets Annual Healthcare Conference
11/17/2009 8:45:39 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) Reports Third Quarter 2009 Financial Results
11/10/2009 10:02:00 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) to Present at Merriman Curhan Ford & Co.'s Investor Summit
11/10/2009 9:34:23 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) to Present at the Oppenheimer Health Care Conference
10/29/2009 9:51:20 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) to Present at the Biotechnology Industry Organization (BIO) Investor Forum
10/22/2009 9:27:57 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) Reports Positive LibiGel(R) Safety Data in Phase III Program
10/20/2009 9:33:15 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Announce Completion of Merger
10/14/2009 11:35:06 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) And Cell Genesys, Inc. (CEGE) Announce Approval of Merger by BioSante Stockholders and Adjournment of Cell Genesys Stockholders Meeting Until October 14, 2009
10/1/2009 10:44:21 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Announce Final Exchange Ratio for Merger
9/23/2009 8:56:01 AM
More...
|
RiskMetrics – ISS Governance Services Recommends Stockholders Vote “FOR” BioSante Pharmaceuticals, Inc. (BPAX) and Cell Genesys, Inc. (CEGE) Merger
9/17/2009 9:21:15 AM
More...
|
|